A Phase 1 Study of Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Veliparib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- Sponsors AbbVie
- 01 Nov 2017 Results published in the Cancer Science
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.